Epizyme, Inc. Insider Trading for September 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Epizyme, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Epizyme, Inc. for September 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 24 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.60 | 20,000 | 12,000 | 56,314 | |
| Sep 24 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 25.55 | 20,000 | 510,990 | 0 | 20 K to 0 (-100.00 %) |
| Sep 24 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.60 | 20,000 | 12,000 | 20,000 | 0 to 20 K |
| Sep 24 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 0.51 | 44,000 | 22,440 | 149,459 | |
| Sep 24 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 0.51 | 44,000 | 22,440 | 138,000 | 94 K to 138 K (+46.81 %) |
| Sep 15 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Option Exercise | M | 2.19 | 2,000 | 4,380 | 278,500 | |
| Sep 15 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Sell | S | 28.67 | 2,000 | 57,340 | 429 | 2.4 K to 429 (-82.34 %) |
| Sep 15 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Buy | M | 2.19 | 2,000 | 4,380 | 2,429 | 429 to 2.4 K (+466.20 %) |
| Sep 15 2014 | EPZM | Epizyme, Inc. | Ho Peter Tai-Ching | Chief Development O ... | Option Exercise | A | 28.20 | 150,000 | 4,230,000 | 150,000 | |
| Sep 05 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 35.14 | 4,000 | 140,560 | 2,825,396 | 2.8 M to 2.8 M (-0.14 %) |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 0.60 | 36,000 | 21,600 | 34,819 | |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 3.54 | 6,000 | 21,240 | 188,833 | |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Sell | S | 33.89 | 5,972 | 202,392 | 94,000 | 100 K to 94 K (-5.97 %) |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Sell | S | 33.37 | 24,028 | 801,771 | 99,972 | 124 K to 100 K (-19.38 %) |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 0.60 | 36,000 | 21,600 | 124,000 | 88 K to 124 K (+40.91 %) |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 3.54 | 6,000 | 21,240 | 88,000 | 82 K to 88 K (+7.32 %) |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Option Exercise | M | 0.51 | 30,000 | 15,300 | 627,223 | |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Sell | S | 33.85 | 6,967 | 235,833 | 0 | 7 K to 0 (-100.00 %) |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Sell | S | 33.35 | 23,033 | 768,068 | 6,967 | 30 K to 7 K (-76.78 %) |
| Sep 04 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Buy | M | 0.51 | 30,000 | 15,300 | 30,000 | 0 to 30 K |